Literature DB >> 7499314

Recombinant core streptavidins. A minimum-sized core streptavidin has enhanced structural stability and higher accessibility to biotinylated macromolecules.

T Sano1, M W Pandori, X Chen, C L Smith, C R Cantor.   

Abstract

Two recombinant core streptavidins were designed and characterized to understand the role of the terminal sequences, present in naturally truncated core streptavidins, in the properties of streptavidin. One recombinant core streptavidin, Stv-25, has an amino acid sequence very similar to natural core streptavidins. The other recombinant molecule, Stv-13, has further truncation of the terminal residues and consists essentially of only the beta-barrel structure characteristic of streptavidin. These recombinant core streptavidins are tetrameric and bind four biotins/molecule, as does natural streptavidin. The solubility characteristics of Stv-13, determined by varying the concentration of ammonium sulfate or ethanol, were almost the same as those of Stv-25 and natural core streptavidin. However, Stv-13 showed an enhanced structural stability compared with Stv-25 and natural core streptavidin. For example, Stv-13 retained greater than 80% of its biotin binding ability after incubation in 6 M guanidine hydrochloride at pH 1.5, under which conditions, Stv-25 and natural core streptavidin retained only about 20% of their biotin binding ability. In addition, Stv-13 showed higher accessibility to biotinylated DNA than natural core streptavidin. Apparently, the terminal regions, present on the surface of natural core streptavidin, spatially hinder biotinylated macromolecules from approaching the biotin binding sites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499314     DOI: 10.1074/jbc.270.47.28204

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Second-contact shell mutation diminishes streptavidin-biotin binding affinity through transmitted effects on equilibrium dynamics.

Authors:  Loren Baugh; Isolde Le Trong; David S Cerutti; Nital Mehta; Susanne Gülich; Patrick S Stayton; Ronald E Stenkamp; Terry P Lybrand
Journal:  Biochemistry       Date:  2012-01-03       Impact factor: 3.162

2.  Dimer-tetramer transition between solution and crystalline states of streptavidin and avidin mutants.

Authors:  Yael Pazy; Yael Eisenberg-Domovich; Olli H Laitinen; Markku S Kulomaa; Edward A Bayer; Meir Wilchek; Oded Livnah
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

3.  Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.

Authors:  Ondrej Stanek; Irena Linhartova; Laleh Majlessi; Claude Leclerc; Peter Sebo
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

4.  Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.

Authors:  Jörg Fahrer; Joschua Funk; Maren Lillich; Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-07       Impact factor: 3.000

5.  Engineered single-chain dimeric streptavidins with an unexpected strong preference for biotin-4-fluorescein.

Authors:  Filiz M Aslan; Yong Yu; Scott C Mohr; Charles R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

6.  A robust method for production of MHC tetramers with small molecule fluorophores.

Authors:  Vasanthi Ramachandiran; Vitalii Grigoriev; Lan Lan; Eugene Ravkov; Suzanne A Mertens; John D Altman
Journal:  J Immunol Methods       Date:  2006-09-22       Impact factor: 2.303

7.  Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.

Authors:  L Pereboeva; S Komarova; J Roth; S Ponnazhagan; D T Curiel
Journal:  Gene Ther       Date:  2007-01-25       Impact factor: 5.250

8.  Directed evolution of streptavidin variants using in vitro compartmentalization.

Authors:  Matthew Levy; Andrew D Ellington
Journal:  Chem Biol       Date:  2008-09-22

9.  A streptavidin mutant with altered ligand-binding specificity.

Authors:  G O Reznik; S Vajda; T Sano; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  A specific aptamer-cell penetrating peptides complex delivered siRNA efficiently and suppressed prostate tumor growth in vivo.

Authors:  Yanjun Diao; Jiayun Liu; Yueyun Ma; Mingquan Su; Hongyi Zhang; Xiaoke Hao
Journal:  Cancer Biol Ther       Date:  2016-03-08       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.